Clinical trial

Comprehensive Assessment of Neurodegeneration and Dementia

NCT03402919

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2016-06-01

PhaseN/A

Study timeline

Study start (actual)2016-06-01Date precision: month

Registry last updated2026-01-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Dementiaunresolved

Mild Cognitive Impairment (MCI)unresolved

Subjective Cognitive Impairmentunresolved

Parkinson's Disease (PD)unresolved

Lewy Body Disease(LBD)unresolved

Mixed Dementiaunresolved

Frontotemporal Dementia (FTD)unresolved

Alzheimer Disease (AD)unresolved

Cognitively Unimpairedunresolved

Subjective Cognitive Decline (SCD)unresolved

Interventions

Sponsors & collaborators

McGill Universitylead sponsor

Canadian Institutes of Health Research (CIHR)collaborator

Alzheimer Society of Canadacollaborator

Sanoficollaborator

New Brunswick Health Research Foundationcollaborator

Saskatchewan Health Research Foundationcollaborator

Michael Smith Foundation for Health Researchcollaborator

Nova Scotia Health Research Foundationcollaborator

Eli Lilly and Companycollaborator

Canadian Nurses Foundation (CNF)collaborator

Ontario Brain Institutecollaborator

Pfizercollaborator

Canadian Consortium on Neurodegeneration in Agingcollaborator

Mapped research locations

TorontoOntario, Canada3 MontrealQuebec, Canada3 LondonOntario, Canada2 VancouverBritish Columbia, Canada1 OttawaOntario, Canada1 EdmontonAlberta, Canada1 CalgaryAlberta, Canada1 HamiltonOntario, Canada1 QuébecQuebec, Canada1 HalifaxNova Scotia, Canada1 SherbrookeQuebec, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03402919 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.